Home  >  Products  >  CASC3 (cancer susceptibility candidate 3) Blocking Peptide (the N terminal of protein) (100ug)
CASC3 (cancer susceptibility candidate 3) Blocking Peptide (the N terminal of protein) (100ug)

CASC3 (cancer susceptibility candidate 3) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CASC3 antibody (Catalogue #: ARP54817_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP54817
Size: 100 ug
Weight: 76kDa
Gene: 22794
Format: Lyophilized powder
Target: The product of this gene is a core component of the exon junction complex (EJC), a protein complex that is deposited on spliced mRNAs at exon-exon junctions and functions in nonsense-mediated mRNA decay (NMD). The encoded protein binds RNA and interacts w
Alternative names: BTZ; MLN51
See Full Product Listings >